These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27760707)

  • 1. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
    Seagle BL; Kanis M; Strohl AE; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
    Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
    Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
    Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
    Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy.
    Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic staging for apparent stage I epithelial ovarian cancer.
    Melamed A; Keating NL; Clemmer JT; Bregar AJ; Wright JD; Boruta DM; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Am J Obstet Gynecol; 2017 Jan; 216(1):50.e1-50.e12. PubMed ID: 27567562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
    Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
    Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
    Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
    Koskas M; Rouzier R; Amant F
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):845-57. PubMed ID: 25817745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in young women with endometrial cancer.
    Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adjuvant radiation in uterine sarcomas.
    Sampath S; Schultheiss TE; Ryu JK; Wong JY
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.
    Matsuo K; Machida H; Takiuchi T; Garcia-Sayre J; Yessaian AA; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):41-49. PubMed ID: 28215841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of early-stage endometrial cancer recurrence-A national cohort study.
    Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
    Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
    Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
    Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
    Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
    Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
    J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.